New U.K.-U.S. trade deal eases industry rebate burden

Large pharmas got their wish on Monday as the U.K. reached a deal with the Trump administration that will keep tariffs off U.K. pharmaceutical exports, and cap how much industry must reimburse the NHS for drug spending, a pain point that had led some companies to halt U.K. investment projects.

The agreement keeps U.S. tariffs off U.K. pharmaceutical exports for the next three years...